Literature DB >> 12093175

Role of heparan sulfate in human parainfluenza virus type 3 infection.

Santanu Bose1, Amiya K Banerjee.   

Abstract

Our current studies have demonstrated that human parainfluenza virus type 3 (HPIV-3) utilizes heparan sulfate (HS) for its efficient cellular entry. HPIV-3 interacted with HS-agarose in vitro and the cellular entry and infection of HPIV-3 were reduced following (a) infection of human epithelial lung A549 cells with HPIV-3 pre-incubated with soluble HS; (b) treatment of A549 cells with heparinase to remove cell surface HS and sodium chlorate (NaClO(3)), a potent inhibitor of proteoglycan sulfation; and (c) infection of HS-deficient mutant CHO cell lines. However, in each instance, complete inhibition of HPIV-3 entry did not occur, suggesting the presence of additional nonproteoglycan cell surface molecule(s) that is required for HPIV-3 entry. Thus the cell surface HS appears to play an important role in efficient cellular entry of HPIV-3. (c) 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093175     DOI: 10.1006/viro.2002.1484

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium.

Authors:  Liqun Zhang; Alexander Bukreyev; Catherine I Thompson; Brandy Watson; Mark E Peeples; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

2.  Decreased dependence on receptor recognition for the fusion promotion activity of L289A-mutated newcastle disease virus fusion protein correlates with a monoclonal antibody-detected conformational change.

Authors:  Jianrong Li; Vanessa R Melanson; Anne M Mirza; Ronald M Iorio
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Learning from the viral journey: how to enter cells and how to overcome intracellular barriers to reach the nucleus.

Authors:  Diky Mudhakir; Hideyoshi Harashima
Journal:  AAPS J       Date:  2009-02-05       Impact factor: 4.009

4.  Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses.

Authors:  Jennifer P Wang; Robert W Finberg; Gabriel L Hendricks; Lourdes Velazquez; Serena Pham; Natasha Qaisar; James C Delaney; Karthik Viswanathan; Leila Albers; James C Comolli; Zachary Shriver; David M Knipe; Evelyn A Kurt-Jones; Deborah K Fygenson; Jose M Trevejo
Journal:  Antiviral Res       Date:  2015-01-28       Impact factor: 5.970

5.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Role of human beta-defensin-2 during tumor necrosis factor-alpha/NF-kappaB-mediated innate antiviral response against human respiratory syncytial virus.

Authors:  Srikanth Kota; Ahmed Sabbah; Te Hung Chang; Rosalinda Harnack; Yan Xiang; Xiangzhi Meng; Santanu Bose
Journal:  J Biol Chem       Date:  2008-06-20       Impact factor: 5.157

7.  Role of nucleolin in human parainfluenza virus type 3 infection of human lung epithelial cells.

Authors:  Santanu Bose; Mausumi Basu; Amiya K Banerjee
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

8.  Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells.

Authors:  Gerald Misinzo; Peter L Delputte; Peter Meerts; David J Lefebvre; Hans J Nauwynck
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

9.  Temporal activation of NF-kappaB regulates an interferon-independent innate antiviral response against cytoplasmic RNA viruses.

Authors:  Santanu Bose; Niladri Kar; Ratan Maitra; Joseph A DiDonato; Amiya K Banerjee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

10.  Beta-catenin associates with human parainfluenza virus type 3 ribonucleoprotein complex and activates transcription of viral genome RNA in vitro.

Authors:  Santanu Bose; Amiya K Banerjee
Journal:  Gene Expr       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.